. Tachybradycardia in the isolated canine right atrium induced by chronic sympathetic stimulation and pacemaker current inhibition. Am J Physiol Heart Circ Physiol 299: H634 -H642, 2010. First published July 2, 2010; doi:10.1152/ajpheart.00347.2010.-The mechanisms of sinoatrial node (SAN) dysfunction in patients with chronically elevated sympathetic tone and reduced pacemaker current (I f; such as heart failure) are poorly understood. We simultaneously mapped membrane potential and intracellular Ca 2ϩ in the Langendorff-perfused canine right atrium (RA). Blockade of either If (ZD-7288) or sarcoplasmic reticulum Ca 2ϩ release (ryanodine) alone decreased heart rate by 8% (n ϭ 3) and 16% (n ϭ 3), respectively. Combined treatment of ZD-7288 and ryanodine consistently resulted in prolonged (Ն3 s) sinus pauses (PSPs) (n ϭ 4). However, the middle SAN remained as the leading pacemaking site after these treatments. Prolonged exposure with isoproterenol (0.01 mol/l) followed by ZD-7288 completely suppressed SAN but triggered recurrent ectopic atrial tachycardia. Cessation of tachycardia was followed by PSPs in five of eight RAs. Isoproterenol initially increased heart rate by 75% from baseline with late diastolic intracellular Ca 2ϩ elevation (LDCAE) from the superior SAN. However, after a prolonged isoproterenol infusion, LDCAE disappeared in the superior SAN, the leading pacemaker shifted to the inferior SAN, and the rate reduced to 52% above baseline. Caffeine (2 ml, 20 mmol/l) injection after a prolonged isoproterenol infusion produced LDCAE in the SAN and accelerated the SAN rate, ruling out sarcoplasmic reticulum Ca 2ϩ depletion as a cause of Ca 2ϩ clock malfunction. We conclude that in an isolated canine RA preparation, chronically elevated sympathetic tone results in abnormal pacemaking hierarchy in the RA, including suppression of the superior SAN and enhanced pacemaking from ectopic sites. Combined malfunction of both membrane and Ca 2ϩ clocks underlies the mechanisms of PSPs. sinoatrial node; calcium; sarcoplasmic reticulum; sympathetic nerve activity SPONTANEOUS DIASTOLIC DEPOLARIZATION of sinoatrial node (SAN) cells periodically initiates action potentials to set the rhythm of the heart. The mechanism of spontaneous diastolic depolarization has been attributed to the rhythmic activation of the pacemaker current (I f ) and other membrane ionic currents ("membrane clock") and the rhythmic spontaneous sarcoplasmic reticulum (SR) Ca 2ϩ release and Na ϩ /Ca 2ϩ exchanger current (I NCX ) activation ("Ca 2ϩ clock") (10, 17). It has been proposed that the membrane clock acts as stabilizer of the pacemaker rate to prevent bradycardia (18, 20) , whereas the Ca 2ϩ clock is primarily responsible for heart rate acceleration during sympathetic stimulation (16). The SAN is a clinically important structure, as failure of SAN rhythm generation may lead to symptomatic bradycardia, known as sick sinus syndrome. While bradycardia is the mechanism of symptoms such as dizziness and presyncope, the onset of bradycardia in sick sinus syndrome is often immediately preceded by tachycardia. Therefore, sick sinus syndrome is often referred to as tachybradycardia syndrome (12). Patients with heart failure typically have abnormal sinus node function. Cessation of rapid pacing in these patients is followed by a prolonged sinus node recovery time (24). Dogs with pacing-induced heart failure may also develop typical spontaneous episodes of tachybradycardia (21). Because heart failure is known to have both chronically increased circulating catecholamines and downregulated I f (6, 29), we hypothesize that I f blockade in the presence of prolonged sympathetic stimulation could produce tachybradycardia in intact canine right atrial (RA) preparations. The purpose of the present study was to test this hypothesis.
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MATERIALS AND METHODS
Langendorff-perfused canine RA preparation. The study protocol was approved by the Institutional Animal Care and Use Committee of Indiana University School of Medicine and the Methodist Research Institute and conforms with guidelines of the American Heart Association. We studied isolated canine RAs in 21 mongrel dogs (22-28 kg) . Hearts were rapidly excised under general anesthesia, and the right coronary artery was perfused with 37°C Tyrode solution equilibrated with 95% O 2-5% CO2 to maintain a pH of 7.4. The composition of Tyrode solution was (in mmol/l) 125 NaCl, 4.5 KCl, 0.25 MgCl 2, 24 NaHCO3, 1.8 NaH2PO4, 1.8 CaCl2, and 5.5 glucose. The coronary perfusion pressure was regulated between 50 and 60 mmHg. Both ventricles and the left atrium were removed, and all visible coronary artery branches were tied off. Contractility was inhibited by 10 -17 mol/l blebbistatin, and the motion artifact was negligible even after the isoproterenol infusion (16) . The pseudo-ECG was recorded with widely spaced bipolar RA electrodes using ISO-DAM8A (World Precision Instruments). RA preparations were equilibrated for Ͼ1 h before baseline measurement (28) .
Assessment of SAN function. SAN recovery time (SNRT) was determined by bipolar pacing with a programmable stimulator (Bloom Associates, Reading, PA) for 30 s at progressively shorter pacing cycle lengths (400, 350, and 300 ms) with the two electrodes placed near the SAN region. The longest time interval from the last paced atrial depolarization to the first spontaneous sinus beat was recorded as the SNRT. The corrected SNRT (cSNRT) was determined by subtracting an average of three sinus cycle lengths before the commencement of atrial pacing from the SNRT.
Dual membrane potential and intracellular Ca 2ϩ recordings. Hearts were stained with rhod-2 AM and RH237 (Molecular Probes, Eugene, OR) and excited with laser light at 532 nm (16) . Fluorescence was collected using two cameras (MiCAM Ultima, BrainVision, Tokyo, Japan) at 1 ms/frame and 100 ϫ 100 pixels with a spatial resolution of 0.35 ϫ 0.35 mm 2 /pixel for 2 s. The SAN area was identified by spontaneous diastolic depolarization and confirmed by histological experiments (trichrome) and by immunostaining of anti-K ϩ /Na ϩ hyperpolarization-activated cyclic nucleotide-gated channel 4 (HCN4). After baseline spontaneous beats had been mapped, the pharmacological interventions were as follows: ZD-7288 (3 mol/l) infusion (n ϭ 3) (8, 16) , ryanodine (3 mol/l) infusion (n ϭ 3), ZD-7288 plus ryanodine infusion (n ϭ 4), low-dose isoproterenol (0.01 mol/l) alone infusion for 140 min (n ϭ 3), and low-dose isoproterenol (0.01 mol/l) infusion for 1 h and followed by ZD-7288 (n ϭ 8), including four RAs in which caffeine (20 mmol/l, 2 ml) was given as a bolus injection before and after the prolonged isoproterenol infusion.
After the combined ZD-7288 and ryanodine infusion, a marked sinus pause was consistently produced. Therefore, to record the first and last spontaneous beats between pauses, only membrane potential (V m) was recorded at 10 ms/frame for 20 s. The fluorescence induced by the laser illumination was obtained through a common lens, separated with a dichroic mirror (650-nm cutoff wavelength), and directed to the respective camera with additional filtering [715-nm long-pass filter for V m and 580 Ϯ 20 nm for intracellular Ca 2ϩ (Ca i 2ϩ )]. Data analysis. We defined tachybradycardia as the alternation of paroxysms of rapid (Ͼ100 beats/min) regular or irregular atrial tachyarrhythmias followed periods of prolonged sinus pauses (PSPs) that exceeded 3 s. Ca i 2ϩ and Vm traces were normalized to their respective peak-to-peak amplitude for a comparison of timing and morphology. The onset of late diastolic Ca i 2ϩ elevation (LDCAE) was defined by the time of the transition between negative to positive values in the dCa i 2ϩ /dt curve. The slopes of LDCAE were measured from the onsets to peak levels of LDCAE. The "90% Ca i 2ϩ relaxation time" was measured from the maximum systolic Ca i 2ϩ to 90% reduction of Ca i 2ϩ (16) . Data are expressed as means Ϯ SE. Student's t-tests with Bonferroni's correction were used to compare the means of two numeric values. ANOVA with Fisher's least-significant-difference post hoc test was used to compare the means among three and four groups. Pearson's 2 -tests were used to compare two categorical variables. P values of Յ0.05 were considered significant.
RESULTS

Effects of membrane clock and Ca
2ϩ clock inhibition in the absence of an isoproterenol infusion. The baseline heart rate of the 21 RA preparations was 88 Ϯ 10 beats/min (76 -110 beats/min). Figure 1A shows that the infusion of ZD-7288 for 30 min deceased heart rate from 89 to 82 beats/min (Ϫ8%). The infusion of ZD-7288 (3 mol/l) reduced heart rate by 8% to 80 Ϯ 4 beats/min (n ϭ 3). The infusion of ryanodine for 30 min, which suppresses the Ca 2ϩ clock by the inhibition of cardiac ryanodine receptor 2 (RyR2), decreased heart rate from 89 to 74 beats/min (Ϫ16%; Fig. 1B ). The ryanodine infusion decreased heart rate by 16% (73.9 Ϯ 8.3 beats/min, n ϭ 3; impaired the regularity of sinus rhythm, producing short and recurrent sinus pauses (Fig. 1B) . These pauses were preceded by transient tachycardia caused by the acceleration of pacemakers in the inferior SAN (Fig. 1C) . Neither ZD-7288 nor ryanodine produced sinus pauses that exceeded 3 s. However, simultaneous use of these two drugs produced PSPs. Fig. 2 shows the effect of a combined infusion of both ZD-7288 (3 mol/l) and ryanodine (3 mol/l) without isoproterenol infusion. Figure 2A shows sinus pauses of 6.9 and 6.3 s. In all 4 dogs treated with both ZD-7288 and ryanodine, 59 episodes of PSPs with a mean duration of 6.4 Ϯ 1.9 s (range: 3-18 s) were produced. Figure 2B shows isochronal maps of the first (a) and last (b) spontaneous beats between the pauses. Both beats originated from the middle SAN. All 171 beats recorded between pauses in this RA originated from the middle SAN. Similarly, in all RAs mapped, the leading pacemakers during combined ZD-7288 and ryanodine treatment were located in the middle SAN and not from the inferior SAN or ectopic sites. The mean of the first cycle length after the pause was significantly shorter than that of the last cycle length (857.8 Ϯ 71.7 vs. 1160.5 Ϯ 212.4 ms, P ϭ 0.001; Fig. 2C ). Although a pause (Ͼ3 s) was successfully generated by blockade of both I f and SR Ca 2ϩ release, typical episodes of tachycardia (Ͼ100 beats/ min) in the tachybradycardia syndrome were not observed. The mean cycle length between the pause was 804 Ϯ 135 ms (range: 710 -1,171 ms).
Effect of a prolonged low-dose isoproterenol infusion on pacemaker hierarchy. Figure 3A shows a typical episode of heart rate change by a prolonged low-dose isoproterenol infusion of 0.01 mol/l followed by a ZD-7288 infusion of 3 mol/l. Figure 3B shows the baseline rhythm generation. The heart rhythm was generated from the middle SAN (sites c and d in Fig. 3B ), and diastolic depolarization was observed from SAN regions (asterisks in Fig. 3B ). Figure 3C shows the response to the isoproterenol infusion during maximum heart rate. The leading pacemaker site was shifted to the superior SAN with LDCAE (asterisks in Fig. 3C, bottom) . In a total of 11 intact canine RAs, low-dose (0.01 mol/l) isoproterenol increased the mean maximum heart rate to 145 Ϯ 21 beats/min (71%) from a baseline of 85 Ϯ 12 beats/min (P ϭ 0.004). However, during the prolonged isoproterenol infusion (Ͼ1 h), heart rate was reduced to 129 Ϯ 19 beats/min (52% from baseline) with disappearance of LDCAE (site d in Fig. 3D ). The reduced heart rate was maintained for 140 min (n ϭ 3, 52% from baseline). The earliest activation site also changed to the inferior SAN (site e in Fig. 3D ). The downward shift of the leading pacemaking site in the SAN was a consistent finding of all RAs studied. These findings indicate that a prolonged low-dose isoproterenol infusion selectively inhibits the superior SAN and changes the hierarchy of pacemaking sites in the SAN. The ZD-7288 (3 mol/l) infusion at this time further decreased heart rate to 92 Ϯ 13 beats/min (8% from baseline; site e in Fig. 3D ) with more inferior shift of the leading pacemaker site (site f in Fig. 3E ). The difference of heart rate between site d (129 Ϯ 19 beats/min) and site e (92 Ϯ 13 beats/min) in Fig. 3A was statistically significant (P ϭ 0.003).
Prolonged isoproterenol and ZD-7288 infusion produced tachybradycardia. We were able to produce an in vitro model of tachybradycardia after prolonged (Ͼ1 h) exposure to lowdose (0.01 mol/L) isoproterenol and subsequent blockade of I f by ZD-7288 in five (63%) of eight RA preparations. Figure 4 shows examples of tachybradycardia recorded from two different canine RAs. Figure 4A shows eight episodes of tachybradycardia. The RA shown in Fig. 4B demonstrated three episodes of tachybradycardia. During 29 episodes of tachybradycardia, the mean of the first cycle length after the pause was significantly longer than that of the last cycle length (1,917.8 Ϯ 457.5 vs. 505.4 Ϯ 148.9 ms, P ϭ 0.001; Fig. 4C ). Acceleration of the heart rate leading to eventual tachycardia can be observed after the PSP in these episodes. Importantly, prolonged isoproterenol infusion was essential in all episodes to produce tachybradycardia. Tachybradycardia was not produced by ZD-7288 alone, without a previous prolonged isoproterenol infusion (n ϭ 5). Note that tachycardia (Ͼ100 beats/min) appeared in the results shown in Fig. 4 but not in Fig. 2 .
The origin of heart beat during tachybradycardia. Figure 5 , A and B, shows optical recordings of the tachybradycardia episode shown in Fig. 4A . During the beginning of tachycardia, the activation originated from the ectopic site of the anterosuperior RA (Fig. 5B) . Before the termination of tachycardia, alternation of heart rhythm was caused by the activation from the lower SAN (beat 2 in Fig. 5B ) and ectopic sites from the inferior RA (beat 3 in Fig. 5B ). After the sinus pause, a spontaneous beat was generated from the inferior SAN without LDCAE (beat 4 in Fig. 5B ). Optical recordings of the RA preparation shown in Fig. 4B are shown in Fig. 5 , C and D. Tachycardia originated from the ectopic site from the inferoposterior RA (beat 1 in Fig. 5D ). The ectopic site from the inferoposterior RA served as the leading pacemaker site until the termination of tachycardia (beat 2 in Fig. 5D ). After a pause of the ectopic beat, the spontaneous beat was produced from the inferior SAN without LDCAE (beat 3 in Fig. 5D ).
Contrary to that found at baseline (before isoproterenol), the leading pacemaking sites after the prolonged isoproterenol infusion were mostly located either at an ectopic site or in the inferior edge of the SAN. Ca i 2ϩ and V m were simultaneously recorded in total 90 beats, including 72 fast beats and 18 slow beats during tachybradycardia. All 18 slow beats originated from the inferior SAN. Among the 72 fast beats, 68 beats (94%) originated from ectopic foci. The remaining four beats were initiated from either the inferior SAN (3 beats) or the superior SAN (1 beat).
Preserved SR Ca 2ϩ content after a prolonged low-dose isoproterenol infusion. To evaluate the cause of impaired superior SAN function after a prolonged low-dose isoproterenol infusion, we injected 2 ml caffeine (20 mmol/l) for 1 s in four RAs. Caffeine produced LDCAE in the SAN without (asterisks in Fig. 6A ) and with a prolonged low-dose isoproterenol infusion (asterisks in Fig. 6B ). Before the prolonged isoproterenol infusion, the leading pacemaker site during caffeine infusion was at the superior SAN in all four RAs. However, after the prolonged isoproterenol infusion, it changed to ectopic foci in all four RAs (P ϭ 0.03). The LDCAE slopes after the prolonged isoproterenol infusion (3.88 Ϯ 0.88 arbitrary units/s) showed no significant differ- ences compared with those before the isoproterenol infusion (3.60 Ϯ 0.74 arbitrary units/s, P ϭ 0.64; Fig. 6C ). Heart rates after the prolonged isoproterenol infusion (172 Ϯ 7 beats/min) showed no significant differences compared with those before the isoproterenol infusion (174 Ϯ 8 beats/min, P ϭ 0.84; Fig. 6D ). This finding suggests that the SR Ca 2ϩ content is preserved after a prolonged low-dose isoproterenol infusion.
Comparison of SNRT, LDCAE slope, and Ca i 2ϩ relaxation time. SNRT was 912 Ϯ 212, 684 Ϯ 45, and 1,144 Ϯ 295 ms and cSNRT was 208 Ϯ 110, 152 Ϯ 38, and 502 Ϯ 203 ms at baseline, after the 5-min isoproterenol infusion, and after the combined ZD-7288 and prolonged isoproterenol infusion, respectively (Fig. 7, A and B, respectively) . Compared with baseline, isoproterenol initially reduced SNRT, but the combined use of prolonged isoproterenol infusion and ZD-7288 significantly increased both SNRT (Fig. 7A) and cSNRT (Fig. 7B ) compared with baseline. Figure 7C shows that the LDCAE slope increased significantly after 5 min of the low-dose isoproterenol infusion, when the isoproterenol effects on heart rate reached their peak. The LDCAE slope then decreased toward baseline after the prolonged isoproterenol infusion and after the addition of ZD-7288 (Fig. 7C) . Figure  7D shows the changes of 90% Ca i 2ϩ relaxation time. Initially, isoproterenol reduced the relaxation time. However, after the prolonged isoproterenol infusion and after the addition of ZD-7288, the relaxation time returned to the baseline level.
DISCUSSION
The primary finding of this study is that ZD-7288 infusion in the presence of a prolonged (Ͼ1 h) isoproterenol infusion results in combined malfunction of the Ca 2ϩ clock and membrane voltage clock in the SAN but, in the meantime, facilitates the development of paroxysmal ectopic atrial tachycardia. Due to combined deficiency of the Ca 2ϩ clock and membrane voltage clock of both the SAN and backup pacemakers, abrupt termination of the tachycardia results in PSP. Because the SAN continued to respond to caffeine at the end of the isoproterenol infusion, the Ca 2ϩ clock malfunction was not due to SR Ca 2ϩ depletion.
Mechanisms of tachybradycardia.
A prolonged (ϳ1 h) isoproterenol infusion simulates persistently elevated sympathetic tone, which is typical in patients with heart failure but can also occur in normal individuals. The persistently elevated sympathetic tone by itself does not induce tachybradycardia. However, I f blockade in the presence of prolonged sympathetic stimulation could produce tachybradycardia. This finding highlights the importance of I f in maintaining normal SAN function under conditions with persistently increased sympathetic tone, such as heart failure. Similar to the experimental condition, heart failure is associated with both chronically elevated sympathetic tone (2) (21) and a concomitant reduction of I f (29) . The chronically increased sympathetic tone is known to have profound effects on cardiac contractile function and arrhyth- mogenesis (7, 22) . However, the effects of chronic catecholamine stimulation on the SAN remains poorly understood. Our study is the first to map Ca 2ϩ clock function in the SAN during a prolonged isoproterenol infusion. The LDCAE slope and 90% Ca i 2ϩ relaxation time reached peak at 5 Ϯ 2 min after the isoproterenol infusion and decreased after the prolonged infusion. A possible explanation of our finding is isoproterenol induced desensitization of the ␤-adrenergic receptor (6, 14) . However, for this explanation to work, it will require a selective desensitization of the ␤-adrenergic receptor in the SAN but not the ectopic sites that generate recurrent ectopic atrial tachyarrhythmias during a prolonged isoproterenol infusion.
Isoproterenol induced phosphorylation of RyR2. An alternative explanation is the accelerated opening and closing of the RyR2 after a prolonged isoproterenol infusion in the superior SAN, which has more robust Ca i 2ϩ cycling than the inferior SAN and nonpacemaking cells in the RA and ventricles (16, 27) . Sympathetic stimulation can result in the phosphorylation of I CaL and phospholamban, leading to increased SR Ca 2ϩ content (26) . It can also phosphorylate RyR2, leading to increased opening probability. A combined increase of SR Ca 2ϩ content and the opening probability of RyR2 is essential in producing arrhythmogenic Ca 2ϩ waves (26) . A recent study by Blayney et al. (4) investigated PKA phosphorylation with binding of FK506-binding proteins to RyRs, including both RyR1 and RyR2. The authors phosphorylated RyR1 and RyR2 using the active subunit of PKA over 1 h. The results showed that the percentage of phosphorylation reached its maximum in 1 h. When phosphorylated, RyR2 opens and closes more quickly. We also found that at least 1 h of isoproterenol infusion is needed to produce tachybradycardia in our preparation. This time course is consistent with the time needed for isoproterenol to activate PKA and maximally phosphorylate RyR2. The balance between the opening and closing of RyR2 determines how much Ca 2ϩ is released from the SR to the cytosol. Consistent with the results of a previous study (15) , we found no evidence of SR Ca 2ϩ depletion in the SAN at the end of the experiment. This finding suggests that reduced SR Ca 2ϩ reuptake is not primarily responsible for SAN dysfunction after a prolonged isoproterenol infusion. Therefore, it is likely that excessively rapid RyR2 closing in the superior SAN may have prevented sufficient spontaneous SR Ca 2ϩ release after a prolonged isoproterenol infusion, leading to PSPs. Finally, at a given E m , the elevated concentration of Ca i 2ϩ slows the recovery of L-type Ca 2ϩ current from inactivation (1) . This latter factor may also have contributed to the development of SAN dysfunction.
Ectopic pacemakers. The pacemaker hierarchy in the RA operates with different mechanisms. The Ca 2ϩ clock in the superior SAN responds robustly to isoproterenol infusion (16) . However, if RyR2 is inhibited by ryanodine, the superior SAN became quiescent during isoproterenol infusion, whereas the ectopic pacemaker sites in the crista terminalis continue to actively respond to isoproterenol and accelerate heart rate (25) . We found that the ectopic pacemakers are highly active after a prolonged isoproterenol infusion, resulting in intermittent ectopic tachycardia while the superior SAN remains dormant. Therefore, heterogeneous and dynamic responses of the pacemaker hierarchy to chronically elevated sympathetic tone play important roles in the generation of tachybradycardia syndrome. We also found that even without isoproterenol infusion, the combined use of ryanodine and ZD-7288 also produced irregular heart rhythms. However, contrary to that found in tachybradycardia, the latter irregular rhythm originated from the middle of the SAN. The mechanism of these irregular rhythms is mostly likely due to I f inhibition, which creates long pauses, allowing the SR to be overfilled with Ca 2ϩ . Although RyR2 is partially inhibited by ryanodine, the luminal Ca 2ϩ of the superior SAN eventually exceeded the RyR2 releasing threshold, leading to sinus tachycardia. The gradual decline of intraluminal Ca 2ϩ then causes a lengthening of sinus cycle length and transient termination of sinus rhythm. The cycle of long pauses and accelerated SAN rate repeats itself, causing irregular SAN rhythm.
Tachycardia-induced intracellular Na ϩ accumulation. An additional possible contributing factor to the occurrence of tachybradycardia is the increased intracellular Na ϩ load (9, 13). The increased intracellular Na ϩ may increase the extrusion of Na ϩ from the cell by Na ϩ -K ϩ -ATPase to produce an increased background repolarizing current, which slows phase 4 diastolic depolarization (5), causing the tachycardia to transiently terminate. Increased intracellular Na ϩ may also suppress the forward mode of I NCX , which prevents Ca i 2ϩ from depolarizing the cell membrane, leading to the termination of the tachycardia. The PSP then allowed sufficient Na ϩ to be extruded through Na ϩ -K ϩ -ATPase and allowed the development of another episode of tachycardia. This additional mechanism is not mutually exclusive with the RyR phosphorylation discussed above. However, tachycardia-induced excessive intracellular Na ϩ accumulation cannot explain the findings of irregular rhythm during combined treatment of ryanodine and ZD-7288.
PSPs occur only if both membrane and Ca 2ϩ clocks are impaired. PSPs were produced only after block of both SR Ca 2ϩ release and I f . Although Ca 2ϩ clock block alone destroyed the regularity of heart rhythm, PSPs did not develop afterward. Clinically, pharmacological agents that suppress I f reduce the heart rate but do not lead to PSPs (11) . Similarly, patients with HCN4 mutation that reduces I f develop benign familial bradycardia but not PSPs or syncope (19) . Patients with RyR2 mutation typically develop bradycardia but not PSPs (3). These findings are consistent with studies (16 -18) that have demonstrated interdependence and synergy between the Ca 2ϩ clock and membrane clock in generating heart betas. A mapping study (25) has also shown that the inferior SAN works as the dominant pacemaker even after blockade of both clock mechanisms, suggesting that the different locations of the SAN may have different dependence of these clocks in generating automaticity.
Study limitations. Because the ectopic foci were not included in the optical mapping field, the exact relationship between Ca i 2ϩ and V m in the generation of ectopic beat cannot be evaluated, but I f is likely to be responsible for the initiation of these ectopic beats. Because vagal innervation is absent in the isolated canine RA preparation, the effects of vagal activation on SAN rate control cannot be determined in the present study. The absence of vagal influence may have contributed to some of the findings of the present study.
Conclusions. Our results from the isolated canine RA show that tachybradycardia occurs by prolonged (Ͼ1 h) exposure to ␤-adrenergic stimulation and a concomitant suppression of I f . Maximal RyR2 phosphorylation and intracellular Na ϩ accumulation in the SAN are possible mechanisms that contribute to the development of tachybradycardia in patients with chronically elevated sympathetic tones.
